一名正在服用艾滋病病毒暴露前预防药物的患者出现多次HIV检测假阳性结果。
Repeated False-Positive HIV Test Results in a Patient Taking HIV Pre-Exposure Prophylaxis.
作者信息
Stekler Joanne D, Violette Lauren R, Niemann Lisa, McMahan Vanessa M, Katz David A, Baeten Jared M, Grant Robert M, Delaney Kevin P
机构信息
Departments of 1Medicine, University of Washington, Seattle, Washington.
Epidemiology, University of Washington, Seattle, Washington.
出版信息
Open Forum Infect Dis. 2018 Sep 26;5(9):ofy197. doi: 10.1093/ofid/ofy197. eCollection 2018 Sep.
Abstract
Regular HIV testing is required to ensure the safety of HIV pre-exposure prophylaxis (PrEP). We describe and discuss a series of false-positive HIV test results from an individual receiving PrEP. The expansion of PrEP will likely result in greater numbers of false-positive test results that may pose challenges for interpretation.
摘要
为确保艾滋病病毒暴露前预防（PrEP）的安全性，需要进行定期的艾滋病病毒检测。我们描述并讨论了一名接受PrEP者出现的一系列艾滋病病毒检测结果假阳性情况。PrEP的推广可能会导致更多假阳性检测结果，这可能会给结果解读带来挑战。
相似文献
1
Repeated False-Positive HIV Test Results in a Patient Taking HIV Pre-Exposure Prophylaxis.一名正在服用艾滋病病毒暴露前预防药物的患者出现多次HIV检测假阳性结果。
Open Forum Infect Dis. 2018 Sep 26;5(9):ofy197. doi: 10.1093/ofid/ofy197. eCollection 2018 Sep.
2
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.接受艾滋病病毒预防用药（PrEP）的非洲男性和女性中艾滋病病毒快速血清学检测假阳性的频率：对生物医学干预措施项目推广的影响
PLoS One. 2015 Apr 17;10(4):e0123005. doi: 10.1371/journal.pone.0123005. eCollection 2015.
3
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.用于预防艾滋病病毒的暴露前预防：安全性问题。
Drug Saf. 2017 Apr;40(4):273-283. doi: 10.1007/s40264-017-0505-6.
4
HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP).孕期的HIV血清转化及暴露前预防（PrEP）的必要性。
HIV AIDS (Auckl). 2018 Apr 17;10:57-61. doi: 10.2147/HIV.S140799. eCollection 2018.
5
Blood safety implications of donors using HIV pre-exposure prophylaxis.使用HIV暴露前预防药物的献血者对血液安全的影响
Vox Sang. 2017 Jul;112(5):473-476. doi: 10.1111/vox.12516. Epub 2017 Mar 31.
6
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.《PrEP Brasil 中男男性行为者和跨性别女性人群使用暴露前预防的保留率、参与率和坚持率：一项示范研究的 48 周结果》
Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18.
7
Trends in Attitudes to and the Use of HIV Pre-exposure Prophylaxis by Australian Gay and Bisexual Men, 2011-2017: Implications for Further Implementation from a Diffusion of Innovations Perspective.澳大利亚男同性恋和双性恋者对 HIV 暴露前预防的态度和使用趋势，2011-2017 年：从创新扩散的角度探讨进一步实施的意义。
AIDS Behav. 2019 Jul;23(7):1939-1950. doi: 10.1007/s10461-018-2368-y.
8
A Strategy for PrEP Clinicians to Manage Ambiguous HIV Test Results During Follow-up Visits.暴露前预防（PrEP）临床医生在随访期间处理模糊HIV检测结果的策略。
Open Forum Infect Dis. 2018 Jul 21;5(8):ofy180. doi: 10.1093/ofid/ofy180. eCollection 2018 Aug.
9
Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).中国男男性行为人群中 HIV 暴露前预防多中心真实世界研究方案（CROPrEP）
BMC Infect Dis. 2019 Aug 15;19(1):721. doi: 10.1186/s12879-019-4355-y.
10
Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.社区对尼日利亚男男性行为者和女性性工作者获得艾滋病毒暴露前预防的障碍和挑战的看法。
BMC Public Health. 2020 Jan 15;20(1):69. doi: 10.1186/s12889-020-8195-x.
引用本文的文献
1
Performance evaluation of the MedMira reveal G4 LAB S/P and POC HIV antibody rapid screening tests using plasma and whole blood specimens.使用血浆和全血样本对MedMira G4 LAB S/P和即时检验（POC）HIV抗体快速筛查检测进行性能评估。
J Clin Virol. 2020 Jun;127:104344. doi: 10.1016/j.jcv.2020.104344. Epub 2020 Apr 11.
2
Prospective Evaluation of HIV Testing Technologies in a Clinical Setting: Protocol for Project DETECT.临床环境中HIV检测技术的前瞻性评估：DETECT项目方案
JMIR Res Protoc. 2020 Jan 27;9(1):e16332. doi: 10.2196/16332.
3
Performance evaluation of four point-of-care HIV tests using unprocessed specimens.使用未经处理的标本对四种即时 HIV 检测进行性能评估。
J Clin Virol. 2020 Mar;124:104282. doi: 10.1016/j.jcv.2020.104282. Epub 2020 Jan 16.
4
Repeated false reactive ADVIA centaur® and bio-rad Geenius™ HIV tests in a patient self-administering anabolic steroids.患者自行使用合成代谢类固醇后，ADVIA Centaur® 和 bio-rad Geenius™ HIV 检测反复出现假阳性反应。
BMC Infect Dis. 2020 Jan 6;20(1):9. doi: 10.1186/s12879-019-4722-8.
5
Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review.暴露前预防（PrEP）、暴露后预防（PEP）、检测即治疗和急性 HIV 感染背景下 HIV 诊断和管理的挑战：范围综述。
J Int AIDS Soc. 2019 Dec;22(12):e25419. doi: 10.1002/jia2.25419.
本文引用的文献
1
A Strategy for PrEP Clinicians to Manage Ambiguous HIV Test Results During Follow-up Visits.暴露前预防（PrEP）临床医生在随访期间处理模糊HIV检测结果的策略。
Open Forum Infect Dis. 2018 Jul 21;5(8):ofy180. doi: 10.1093/ofid/ofy180. eCollection 2018 Aug.
2
Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.支持加利福尼亚州洛杉矶男男性行为者坚持使用替诺福韦酯/恩曲他滨进行暴露前预防以预防艾滋病毒的血浆替诺福韦水平
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):501-511. doi: 10.1097/QAI.0000000000001538.
3
Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure.HIV 检测反应出现时间：对解释检测结果和暴露后重新检测的影响
Clin Infect Dis. 2017 Jan 1;64(1):53-59. doi: 10.1093/cid/ciw666. Epub 2016 Oct 12.
4
Improved Sensitivity of a Dual-Target HIV-1 Qualitative Test for Plasma and Dried Blood Spots.用于血浆和干血斑的双靶点HIV-1定性检测的灵敏度提高
J Clin Microbiol. 2016 Jul;54(7):1877-1882. doi: 10.1128/JCM.00128-16. Epub 2016 May 18.
5
Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM.西雅图男男性行为者中Determine Combo及其他即时检测HIV检测方法的性能表现
J Clin Virol. 2016 Mar;76:8-13. doi: 10.1016/j.jcv.2015.12.011. Epub 2016 Jan 2.
6
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.接受艾滋病病毒预防用药（PrEP）的非洲男性和女性中艾滋病病毒快速血清学检测假阳性的频率：对生物医学干预措施项目推广的影响
PLoS One. 2015 Apr 17;10(4):e0123005. doi: 10.1371/journal.pone.0123005. eCollection 2015.
7
Streamlining HIV testing for HIV preexposure prophylaxis.简化用于艾滋病病毒暴露前预防的艾滋病病毒检测流程。
J Clin Microbiol. 2015 Jan;53(1):179-83. doi: 10.1128/JCM.01540-14. Epub 2014 Nov 5.
8
Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).一项随机试验中口服剂量与替诺福韦毛发水平之间的紧密关系：毛发作为暴露前预防（PrEP）潜在依从性测量指标。
PLoS One. 2014 Jan 8;9(1):e83736. doi: 10.1371/journal.pone.0083736. eCollection 2014.
9
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.接受暴露前预防（PrEP）的男男性行为者的恩曲他滨替诺福韦浓度与预防效果。
Sci Transl Med. 2012 Sep 12;4(151):151ra125. doi: 10.1126/scitranslmed.3004006.
10
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.男男性行为人群 HIV 预防的暴露前药物预防。
N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.
Zotero 插件